- Home
- CRMD vs AGL Comparison
CRMD vs AGL Comparison
Compare CRMD & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- AGL
- Stock Information
- Founded
- CRMD 2006
- AGL 2016
- Country
- CRMD United States
- AGL United States
- Employees
- CRMD N/A
- AGL N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- AGL Managed Health Care
- Sector
- CRMD Health Care
- AGL Health Care
- Exchange
- CRMD Nasdaq
- AGL Nasdaq
- Market Cap
- CRMD 901.8M
- AGL 952.1M
- IPO Year
- CRMD 2010
- AGL 2021
- Fundamental
- Price
- CRMD $13.69
- AGL $1.33
- Analyst Decision
- CRMD Strong Buy
- AGL Hold
- Analyst Count
- CRMD 7
- AGL 20
- Target Price
- CRMD $16.83
- AGL $3.09
- AVG Volume (30 Days)
- CRMD 3.4M
- AGL 22.2M
- Earning Date
- CRMD 08-07-2025
- AGL 08-04-2025
- Dividend Yield
- CRMD N/A
- AGL N/A
- EPS Growth
- CRMD N/A
- AGL N/A
- EPS
- CRMD 0.79
- AGL N/A
- Revenue
- CRMD $121,484,498.00
- AGL $5,901,182,000.00
- Revenue This Year
- CRMD $278.96
- AGL N/A
- Revenue Next Year
- CRMD $45.85
- AGL $10.13
- P/E Ratio
- CRMD $17.30
- AGL N/A
- Revenue Growth
- CRMD 14970.29
- AGL 11.76
- 52 Week Low
- CRMD $4.87
- AGL $0.71
- 52 Week High
- CRMD $17.43
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- CRMD 65.34
- AGL 43.73
- Support Level
- CRMD $12.80
- AGL $1.17
- Resistance Level
- CRMD $13.56
- AGL $1.28
- Average True Range (ATR)
- CRMD 0.86
- AGL 0.14
- MACD
- CRMD 0.27
- AGL 0.06
- Stochastic Oscillator
- CRMD 84.47
- AGL 96.09
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.